ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Money raised by industrial, drug funds

by Michael McCoy
October 24, 2016 | APPEARED IN VOLUME 94, ISSUE 42

Arsenal Capital Partners has raised $1.3 billion for its fourth investment fund. The New York City-based private equity firm invests in lower middle-market specialty industrial and health care companies. Current investments include the radiation cure resins maker IGM Resins and the drug development software firm Certara. Meanwhile, Sofinnova Partners has raised $650 million for its latest biotech investment fund. The fund plans to invest between $15 million and $35 million in 20 to 25 companies. Sofinovva says it has invested in 46 drug companies since 2007.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment